For a patient with gout who is on hydrochlorothiazide, what is the recommended management of an acute gout flare?

Management of Gout Flares in a Patient on Hydrochlorothiazide

You should strongly consider discontinuing or switching the hydrochlorothiazide to an alternative antihypertensive agent, as thiazide diuretics directly precipitate hyperuricemia and gout flares, then treat the acute flare with corticosteroids as first-line therapy. 1

Immediate Management: Address the HCTZ Problem

The FDA label explicitly warns that "hyperuricemia or acute gout may be precipitated in certain patients receiving thiazide diuretics" 1. This is not a minor side effect—HCTZ is actively working against your gout management by:

• Decreasing uric acid excretion
• Raising serum urate levels
• Triggering recurrent flares

Switch HCTZ to:

• Calcium channel blockers (e.g., amlodipine)
• ACE inhibitors or ARBs (if not already on them)
• Losartan specifically has mild uricosuric properties

This medication change is foundational—continuing HCTZ while trying to manage gout is like bailing water from a boat with the drain plug removed.

Treating the Acute Flare

For the current gout flare, use corticosteroids as first-line therapy 2. The 2017 ACP guidelines specifically state that corticosteroids should be considered first-line because they are "generally safer and a low-cost treatment option" with effectiveness equal to NSAIDs but fewer adverse effects 2.

Specific regimen: Prednisolone 35 mg daily for 5 days 2

Alternative Options (in order of preference):

1. NSAIDs - Effective but watch for contraindications 2:

   • Avoid if: renal disease, heart failure, cirrhosis, or GI bleeding risk
   • Any NSAID works equally well (indomethacin has no superiority despite tradition) 2

2. Low-dose colchicine 2:

   • Dosing: 1.2 mg followed by 0.6 mg one hour later, then 0.5 mg 2-3 times daily 2
   • More expensive than corticosteroids/NSAIDs
   • Critical contraindication: Do NOT use if patient has renal impairment AND is taking CYP3A4 or P-glycoprotein inhibitors 2
   • Reduce dose in chronic kidney disease 2

Long-Term Management Strategy

Should You Start Urate-Lowering Therapy (ULT)?

This depends on flare frequency:

If ≥2 flares per year: Initiate ULT with shared decision-making 2

If <2 flares per year: Do NOT start long-term ULT 2. The ACP strongly recommends against ULT in patients with infrequent attacks (strong recommendation, moderate-quality evidence).

If Starting ULT:

1. First-line agent: Allopurinol 3

   • Start LOW: ≤100 mg/day (even lower if CKD stage ≥3) 3
   • Titrate up gradually to target serum urate <6 mg/dL

2. Mandatory prophylaxis when starting ULT 3:

   • Use low-dose colchicine, NSAIDs, or prednisone
   • Continue for 3-6 months minimum (strong recommendation) 3
   • ULT paradoxically increases flare risk in first 6 months 2

3. You CAN start ULT during an active flare if indicated—don't wait for resolution 3

Common Pitfalls to Avoid

1. Continuing HCTZ while treating gout - This guarantees treatment failure
2. Starting ULT without prophylaxis - Will precipitate more flares
3. Using high-dose colchicine - No better efficacy, more GI side effects 2
4. Starting allopurinol at 300 mg - Increases flare risk and hypersensitivity reactions 3
5. Stopping ULT after one flare resolves - This is a chronic disease requiring long-term management if flares are frequent

The Bottom Line Algorithm

1. Stop HCTZ → Switch to alternative antihypertensive
2. Treat acute flare → Corticosteroids first-line (prednisolone 35 mg × 5 days)
3. Count flares over past year:
   - <2 flares/year → No ULT needed
   - ≥2 flares/year → Start allopurinol ≤100 mg/day WITH prophylaxis × 3-6 months
4. Titrate allopurinol to serum urate <6 mg/dL

The medication reconciliation (removing HCTZ) is as important as treating the flare itself—this addresses the root cause rather than just managing symptoms.